Cargando…

Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs

BACKGROUND: Rabacfosadine (RAB), a novel antineoplastic agent conditionally licensed for the treatment of lymphoma in dogs, is efficacious in both naïve and previously treated dogs. Its use in combination with L‐asparaginase (L‐ASP) has not been studied. HYPOTHESIS/OBJECTIVES: To evaluate the safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cawley, Jacob R., Wright, Zachary M., Meleo, Karri, Post, Gerald S., Clifford, Craig A., Vickery, Kathryn R., Vail, David M., Bergman, Philip J., Thamm, Douglas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096650/ https://www.ncbi.nlm.nih.gov/pubmed/32064697 http://dx.doi.org/10.1111/jvim.15723

Ejemplares similares

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma
por: Thamm, D.H., et al.
Publicado: (2017)

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)

Erratum for Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
Publicado: (2020)

Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials
por: Saba, Corey F., et al.
Publicado: (2020)

Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
por: Siewert, Jacob M., et al.
Publicado: (2023)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Axial Multicentric Osteosarcoma in an English Cocker Spaniel
por: Parzefall, B., et al.
Publicado: (2016)

Bronchoscopy, Imaging, and Concurrent Diseases in Dogs with Bronchiectasis: (2003–2014)
por: Johnson, L.R., et al.
Publicado: (2016)

Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus
por: Fletcher, J.M., et al.
Publicado: (2016)

Prognostic value of fluorine(18) flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma
por: Griffin, Lynn R., et al.
Publicado: (2019)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy
por: Faulhaber, Erica A., et al.
Publicado: (2021)

Tick‐Borne Relapsing Fever in Dogs
por: Piccione, J., et al.
Publicado: (2016)

Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma
por: Moore, A Russell, et al.
Publicado: (2020)

Posaconazole treatment of refractory coccidioidomycosis in dogs
por: Shubitz, Lisa F., et al.
Publicado: (2021)

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs
por: Khanna, C., et al.
Publicado: (2015)

Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism
por: van Bokhorst, Kirsten L., et al.
Publicado: (2018)

Clinical features of muscle stiffness in 37 dogs with concurrent naturally occurring hypercortisolism
por: Golinelli, Stefania, et al.
Publicado: (2023)

Accuracy of Crit‐Line® monitors in predicting hematocrit and change in blood volume of dogs during hemodialysis
por: Vickery, Whitney E., et al.
Publicado: (2023)

Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog
por: Loewen, Jennifer M., et al.
Publicado: (2018)

Large T‐cell extradural lymphoma with concurrent marked cerebrospinal fluid eosinophilia in a dog
por: Massie, Anna M., et al.
Publicado: (2023)

Prospective evaluation of the lymph node proteome in dogs with multicentric lymphoma supplemented with sulforaphane
por: Parachini‐Winter, Cyril, et al.
Publicado: (2020)

Antigen Concentrations as an Indicator of Clinical Remission and Disease Relapse in Cats with Histoplasmosis
por: Hanzlicek, A.S., et al.
Publicado: (2016)

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs
por: Poirier, V.J., et al.
Publicado: (2017)

Incidence of relapse of inflammatory protein‐losing enteropathy in dogs and associated risk factors
por: Green, Jodie, et al.
Publicado: (2022)

Canine Cutaneous Plasmacytosis: 21 Cases (2005–2015)
por: Boostrom, B.O., et al.
Publicado: (2017)

Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations
por: Page, R., et al.
Publicado: (2016)

Patterns of local residual disease and local failure after intensity modulated/image guided radiation therapy for sinonasal tumors in dogs
por: Poirier, Valerie J., et al.
Publicado: (2021)

Influence of concurrent lower respiratory tract disease on point‐of‐care lung ultrasound in small‐breed dogs with myxomatous mitral valve disease
por: Lam, Man‐Cham, et al.
Publicado: (2022)

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non‐Hodgkin lymphoma
por: Boyé, Pierre, et al.
Publicado: (2019)

CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs
por: Carter, Gabrielle L., et al.
Publicado: (2021)

Validation of a Multiplexed Gene Signature Assay for Diagnosis of Canine Cancers from Formalin‐Fixed Paraffin‐Embedded Tissues
por: Davis, B., et al.
Publicado: (2017)

Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs
por: Estruch, Juan, et al.
Publicado: (2021)

Evaluation of antimicrobial prescriptions in dogs with suspected bacterial urinary tract disease
por: Weese, Jeffrey Scott, et al.
Publicado: (2021)

Outcomes of esophageal and gastric bone foreign bodies in dogs
por: Barash, Nanelle R., et al.
Publicado: (2022)

Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
por: Axiak‐Bechtel, Sandra M., et al.
Publicado: (2023)

Prediction of outcome after ligation or thin film banding of extrahepatic shunts, based on plasma albumin concentration and hematologic expression of 8 target genes in 85 dogs
por: van Blokland‐Post, Krista, et al.
Publicado: (2023)

Novel genomic prognostic biomarkers for dogs with cancer
por: Chon, Esther, et al.
Publicado: (2023)

Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders
por: Mariani, Christopher L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uotpkhs3nce40ncginrun615oi